等级
for HPLC derivatization
质量水平
蒸汽密度
2.69 (vs air)
蒸汽压
1 mmHg ( 20 °C)
检测方案
≥99.0% (GC)
形式
liquid
质量
LiChropur™
expl. lim.
18 %
浓度
14.3 M (pure liquid)
技术
HPLC: suitable
折射率
n20/D 1.500 (lit.)
n20/D 1.500-1.502
bp
157 °C (lit.)
密度
1.114 g/mL at 25 °C (lit.)
储存温度
2-8°C
SMILES字符串
OCCS
InChI
1S/C2H6OS/c3-1-2-4/h3-4H,1-2H2
InChI key
DGVVWUTYPXICAM-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
一般描述
2-巯基乙醇是一种硫醇化合物,在体外对小鼠淋巴瘤L1210细胞显示出生长促进作用。它还能增强淋巴细胞培养物的活性、胚细胞转化和抗体形成。
应用
BME 适用于在聚丙烯酰胺凝胶电泳前还原蛋白质二硫键,通常用于 SDS-PAGE 的样品缓冲液,浓度为 5%。 切割分子间(亚基之间)二硫键允许蛋白质的亚基在 SDS-PAGE 上独立分离。 切割分子内(亚基内)二硫键可使亚基完全变性,从而使每个肽根据其链长迁移,而不受二级结构的影响。
适用于胺基团的衍生化
法律信息
LiChropur is a trademark of Merck KGaA, Darmstadt, Germany
警示用语:
Danger
危险分类
Acute Tox. 2 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 2 - Eye Dam. 1 - Repr. 2 - Skin Irrit. 2 - Skin Sens. 1A - STOT RE 2 Oral
靶器官
Liver,Heart
WGK
WGK 3
法规信息
危险化学品
Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine
The Journal of Biological Chemistry, 256(23), 12387-12392 (1981)
Blood, 123(23), 3622-3634 (2014-04-24)
Previous studies demonstrated that imatinib mesylate (IM) induces autophagy in chronic myeloid leukemia (CML) and that this process is critical to cell survival upon therapy. However, it is not known if the autophagic process differs at basal levels between CML
The Journal of infectious diseases, 211(3), 416-425 (2014-08-21)
Na-ASP-2 is an efficacious hookworm vaccine antigen. However, despite elucidation of its crystal structure and studies addressing its immunobiology, the function of Na-ASP-2 has remained elusive. We probed a 9000-protein human proteome microarray with Na-ASP-2 and showed binding to CD79A
Human molecular genetics, 23(11), 2968-2980 (2014-01-15)
The disease mechanism of Rett syndrome (RTT) is not well understood. Studies in RTT mouse models have suggested a non-cell-autonomous role for astrocytes in RTT pathogenesis. However, it is not clear whether this is also true for human RTT astrocytes.
Cancer immunology research, 2(8), 741-755 (2014-06-12)
Antibody-drug conjugates (ADC) are emerging as powerful treatment strategies with outstanding target-specificity and high therapeutic activity in patients with cancer. Brentuximab vedotin represents a first-in-class ADC directed against CD30(+) malignancies. We hypothesized that its sustained clinical responses could be related
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门